Balaji-Biotech Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 20.29 Cr
as on 16-11-2024
- Company Age 30 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.47 Cr
as on 16-11-2024
- Satisfied Charges ₹ 55.45 Cr
as on 16-11-2024
- Revenue 430083.36%
(FY 2023)
- Profit -5.88%
(FY 2023)
- Ebitda -9.54%
(FY 2023)
- Net Worth 17.68%
(FY 2023)
- Total Assets 16.17%
(FY 2023)
About Balaji-Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 20.29 Cr.
The company currently has active open charges totaling ₹42.47 Cr. The company has closed loans amounting to ₹55.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Balaji-Biotech Limited India are Krishna Muttineni as Ceo, Nagaraju as Cfo, and Priya Mehta as Company Secretary. Krishna Muttineni, Saisamyaksha Kondlapudi, Kondlapudi Lakshmi, and One other member serve as directors at the Company.
- CIN/LLPIN
U72200TN1994PLC129670
- Company No.
129670
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Feb 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Balaji-Biotech?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Muttineni  | CEO | 21-Jun-2021 | Current |
| Nagaraju | CFO | 21-Jun-2021 | Current |
| Priya Mehta | Company Secretary | 01-Jun-2021 | Current |
| Saisamyaksha Kondlapudi | Managing Director | 29-Jun-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Muttineni | Director and Ceo | 29-Jun-2021 | Current |
| Kondlapudi Lakshmi | Director | 29-Jun-2021 | Current |
| Kondalapudi Reddy | Director | 29-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Balaji-Biotech.
Balaji-Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 430083.36% increase. The company also saw a slight decrease in profitability, with a 5.88% decrease in profit. The company's net worth Soared by an impressive increase of 17.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Balaji-Biotech?
In 2023, Balaji-Biotech had a promoter holding of 6.74% and a public holding of 93.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kences Container Terminal LimitedActive 22 years 5 monthsKondlapudi Lakshmi and Kondalapudi Reddy are mutual person
Kences Constructions Private LimitedActive 23 years 8 daysKrishna Muttineni, Saisamyaksha Kondlapudi and 2 more are mutual person
A R Kences Steel Industries Private LimitedActive 29 years 3 monthsKrishna Muttineni and Kondalapudi Reddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Ltd. Creation Date: 25 Mar 1996 | ₹15.00 Cr | Open |
Global Trust Bank Limited Creation Date: 15 Mar 1995 | ₹9.25 Cr | Open |
Icici Bank Ltd. Creation Date: 25 May 1994 | ₹3.22 Cr | Open |
How Many Employees Work at Balaji-Biotech?
Unlock and access historical data on people associated with Balaji-Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Balaji-Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Balaji-Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
.webp){kind=small}
